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Original Article
Normal-tension glaucoma (NTG) is characterized by the 
chronic degeneration of retinal ganglion cells (RGCs). The 
longitudinal examination of the disease broadly consists of 
the structural evaluation of the optic nerve head and sur-
rounding retinal nerve fiber layer (RNFL) and the func-
Purpose: This study aimed to compare the clinical characteristics of patients who showed structural progression in the peri-
papillary retinal nerve fiber layer (RNFL) first against those who showed progression in the macular ganglion cell-inner plexi-
form layer (GCIPL) first and to investigate clinical parameters that help determine whether a patient exhibits RNFL or GCIPL 
damage first. 
Methods: A retrospective review of medical records of patients diagnosed with early-stage normal-tension glaucoma was 
performed. All eyes underwent intraocular pressure measurement with Goldmann applanation tonometer, standard auto-
mated perimetry, and Cirrus optical coherence tomography at 6-month intervals. Structural progression was determined 
using the Guided Progression Analysis software. Blood pressure was measured at each visit. 
Results: Forty-one eyes of 41 patients (mean age, 52.6 ± 16.7 years) were included in the study. In 21 eyes, structural pro-
gression was first detected in the RNFL at 54.2 ± 14.8 months, while structural progression was first observed at the macular 
GCIPL at 40.5 ± 11.0 months in 20 eyes. The mean intraocular pressure following treatment was 13.1 ± 1.8 mmHg for the 
RNFL progression first group and 13.4 ± 1.8 mmHg for the GCIPL progression first group (p = 0.514). The GCIPL progression 
first group was older (p = 0.008) and had thinner RNFL at baseline (p = 0.001). The logistic regression analyses indicated that 
both age and follow-up duration until first progression predicted the region of structural progression (odds ratio, 1.051; 95% 
confidence interval, 1.001–1.105; p = 0.046 for age; odds ratio, 0.912; 95% confidence interval, 0.840–0.991; p = 0.029 for 
time until progression).
Conclusions: Age of glaucoma patients and time until progression are associated with the region of the first structural pro-
gression in normal-tension glaucoma. Further studies exploring the association between glaucomatous progression and the 
location of damage are needed. 
Key Words: Disease progression, Low tension glaucoma, Optical coherence tomography
Korean J Ophthalmol 2020;34(4):322-333
https://doi.org/10.3341/kjo.2020.0011
Received: February 7, 2020    Final revision: April 14, 2020
Accepted: April 23, 2020
Corresponding Author: Hyoung Won Bae, MD. Department of Ophthal-
mology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodae-
mun-gu, Seoul 03722, Korea. Tel: 82-2-2228-3570, Fax: 82-2-312-0541, 
E-mail: baekwon@yuhs.ac
Clinical Predictors of the Region of First Structural Progression in 
Early Normal-tension Glaucoma
Jihei Sara Lee1, Kwanghyun Lee1,2, Gong Je Seong1, Chan Yun Kim1, Sang Yeop Lee1, Hyoung Won Bae1
1Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, 
Korea
2Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Korea
323
JS Lee, et al. GCIPL Progression vs. RNFL Progression
tional evaluation of the visual field (VF). For monitoring of 
structural damage, spectral-domain optical coherence to-
mography (OCT) has become an integral component [1]. 
This noninvasive imaging modality provides quantitative 
analyses of the peripapillary RNFL thickness with high 
sensitivity and reproducibility [2]. However, the RNFL 
analysis has shown limited usefulness in advanced glauco-
ma as it reaches the measurement floor [3,4].
In 1998, Zeimer et al. [5] first proposed that changes in 
retinal thickness at the macula may be an indicator of the 
structural damage in NTG based on the anatomic evidence 
that almost half of the RGCs are aggregated in the macular 
region. Since then, many studies have put the macular 
analysis to the test [6-8]. Current evidences so far suggest 
that not only is assessing the ganglion cell-inner plexiform 
layer (GCIPL) at the macula a reliable alternative to mea-
suring peripapillary RNFL thickness in advanced stages 
of the disease [9], but it is also an effective indicator of 
structural damage progression in early stages [10,11]. In 
fact, reports of patients showing signs of ganglion cell 
damage at the macula first instead of the peripapillary 
RNFL are mounting [12,13].  
However, no studies to date have extensively character-
ized and compared patients that dominantly show their 
first progression at the peripapillary RNFL against those 
who show damage at the macular GCIPL first. In light of 
the above, this study sought to identify clinical parameters 
associated with the region of the first structural progres-
sion in NTG. 
Materials and Methods
Study population
A retrospective, prerecruitment chart review of patients 
who visited the glaucoma clinic at Severance Hospital was 
conducted. Among 140 patients who received a diagnosis 
of NTG between January 2010 and August 2019, patients 
who were older than 20 years of age were considered eligi-
ble for inclusion in this study. A diagnosis of NTG was 
made when glaucomatous optic disc changes (i.e., localized 
or diffuse neuroretinal rim thinning or a difference in the 
cup-to-disc ratio greater than 0.2 between two eyes) were 
identified on stereo-disc photographs and the presence of 
RNFL defect was noted on either red-free fundus photos 
or Cirrus OCT (Carl Zeiss AG, Oberkochen, Germany). 
The presence of glaucomatous VF defects was not required 
for diagnosis. The following exclusion criteria were ap-
plied for the final selection of the study population: (1) any 
history of ocular surgery other than uncomplicated cata-
ract surgery, (2) history of other ocular disease that may 
increase intraocular pressure (IOP) and cause secondary 
glaucoma, (3) systemic ocular pathology known to affect 
the optic disc, (4) moderate to advanced glaucoma (lowest 
mean deviation worse than -6 dB by field analyzer mea-
surement), (5) less than 6 high signal strength (>6 / 10) Cir-
rus OCT tests, (6) failure to undergo two consecutive reli-
able baseline VF examinations (a reliable VF test was 
defined as fixation loss ≤33%, false-negative rate ≤33%, 
and false-positive rate ≤15%), and (7) absence of the 
demonstration of structural damage progression at any re-
gion during Cirrus OCT testing during follow-up. When 
both eyes of a single patient were eligible for inclusion, one 
eye was chosen at random. Patients with preperimetric 
glaucoma showing glaucomatous optic neuropathy in the 
absence of corresponding VF defects as well as early-stage 
glaucoma with glaucomatous optic neuropathy, corre-
sponding VF defects and the mean deviation less than -6 
dB were recruited. Finally, a total of 41 eyes were included 
in this study. 
The study protocol adhered to the tenets of the Declara-
tion of Helsinki and was approved by the institutional re-
view board of the Severance Hospital at Yonsei University 
College of Medicine (4-2019-0835). All participants pro-
vided written informed consent after receiving an explana-
tion about the nature and consequences of the study. 
Ophthalmologic evaluation
All patients underwent complete ophthalmologic exam-
inations at their initial visit. A review of the underlying 
medical history and measurements of visual acuity, refrac-
tion error, and central corneal thickness were performed. 
Slit-lamp examinations, gonioscopy and dilated fundus ex-
amination with a 90D lens were also conducted. IOP was 
measured with a Goldmann applanation tonometer 
(Haag-Streit model BQ-900; Haag-Streit, Bern, Switzer-
land). The initial examination also included color disc ste-
reophotography, red-free fundus photography, standard au-
tomated perimetry (24-2 SITA standard, Humphrey Field 
Analyzer II; Carl Zeiss AG, Oberkochen, Germany) and 
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Cirrus OCT. After diagnosis, patients were followed every 6 
months. For each visit, patients underwent assessments of 
visual acuity, IOP, slit-lamp biomicroscopy, stereoscopic op-
tic-disc photography, VF test, red-free fundus photography, 
Cirrus OCT, and systemic blood pressure measurement. 
Maximum and minimum blood pressures were recorded for 
Fig. 1. A representative patient showing structural progression first at the peripapillary retinal nerve fiber layer (RFNL). The thickness 
maps and thickness change maps of the peripapillary RNFL (A) and macular ganglion cell-inner plexiform layer (GCIPL) (B) are pre-
sented. Thickness changes are also indicated on graphs for the peripapillary RNFL (C) and macular GCIPL (D). The representative pa-
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each patient; the fluctuation in blood pressure was taken as 
the standard deviation of all blood pressures measured 
during follow-up.
The average IOP from three repeated measurements 
during separate follow-up visits were averaged and recorded 
as the baseline IOP. The percentage of reduction was defined 
Fig. 2. A representative patient showing structural progression first at the macular ganglion cell-inner plexiform layer (GCIPL). The 
thickness maps and thickness change maps of the peripapillary retinal nerve fiber layer (RNFL) (A) and macular GCIPL (B) are present-
ed. Thickness changes indicated on graphs for the peripapillary RNFL (C) and macular GCIPL (D) suggested progressive thinning of 
macular GCIPL first before the thinning of RNFL. The structural progression in this representative individual was first confirmed during 
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as the difference between the baseline IOP and the mean 
IOP divided by the baseline IOP. The standard deviation of 
all IOP measurements collected during follow-up was con-
sidered to be the IOP fluctuation. The percentage difference 
at the time of structural progression was taken to be the val-
ue obtained by subtracting the IOP at the time of progres-
sion from the mean IOP and dividing that value by the mean 
IOP. By masked assessment of optic-disc stereophotographs, 
optic-disc hemorrhage was detected when a sign of hemor-
rhage was found within one disc-diameter of the optic disc 
border without any association with optic-disc edema, papil-
litis, diabetic retinopathy, or retinal vein occlusion.
Determination of structural progression
The structural progression was determined using the 
Guided Progression Analysis of Cirrus OCT ver. 6.0 soft-
ware (Carl Zeiss AG). In short, the algorithm aligns super-
pixels (4 × 4 pixels) and measures the thickness at each su-
perpixel. The initial two examinations were set as the 
baseline and changes at individual superpixels from the 
baseline through follow-up were noted. The trend-based 
progression analysis uses the aligned images and performs 
linear regression analyses between the change in the thick-
ness at each superpixel and the follow-up time. When a 
significant trend is noted in 20 contiguous superpixels in 
the linear regression, the change is marked as a significant 
progression. The rate of change at either the peripapillary 
RNFL or macular GCIPL was recorded. The event analy-
sis marks a data point yellow to indicate a possible loss 
when the thickness value falls outside of the range of 
test-retest variability. When the subsequent follow-up scan 
confirms the change, the area is marked in red to denote a 
likely loss. To determine progression, event analysis was 
employed; changes marked in red as likely losses were tak-
en to strongly suggest structural progression [14]. Out of 41 
Table 1. Comparison of baseline clinical characteristics and medical history between patients with RNFL progression first and 
GCIPL progression first
 RNFL first (n = 21) GCIPL first (n = 20) p-value
Age (yr) 46.3 ± 17.3 60.9 ± 16.2 0.008*
Sex, male 13 (61.9) 11 (55.0) 0.895†
Systemic condition
Hypertension 5 (23.8) 10 (50.0) 0.417†
Diabetes mellitus 4 (19.0) 0 (0.0) 0.126†
Blood pressure (mmHg)
Mean SBP 119.1 ± 13.7 125.6 ± 10.3 0.096*
Maximum SBP 133.6 ± 16.4 139.3 ± 10.9 0.194*
Minimum SBP 105.1 ± 13.0 112.5 ± 10.9 0.058*
SBP fluctuation 9.8 (7.3–12.0) 10.0 (6.8–12.8) 0.862‡
Mean DBP 71.3 ± 8.4 73.4 ± 7.5 0.410*
Maximum DBP 80.0 (75.0–89.0) 80.0 (77.5–87.0) 0.628‡
Minimum DBP 61.5 ± 9.4 63.0 ± 7.3 0.567*
DBP fluctuation 7.9 ± 3.3 7.4 ± 2.4  0.598*
Mean arterial pressure 87.2 ± 9.9 90.8 ± 7.4 0.207*
Time until progression (mon) 54.2 ± 14.8 40.5 ± 11.0 0.002*
Values are presented as mean ± standard deviation, number (%), or median (range); p < 0.05 was considered to be statistically significant.
RNFL = retinal nerve fiber layer; GCIPL = ganglion cell-inner plexiform layer; SBP = systolic blood pressure; DBP = diastolic perfusion 
pressure.
*Student’s t-test, †Chi-squared test; ‡Mann-Whitney U-test.
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Table 2. Comparison of ocular characteristics between patients with RNFL progression first and GCIPL progression first
 RNFL first (n = 21) GCIPL first (n = 20) p-value
CCT (μm) 542.7 ± 45.0 514.5 ± 31.9 0.045*
Axial length (mm) 25.4 ± 2.3  24.1 ± 1.3  0.206*
Visual field
Baseline MD (dB) -2.6 ± 1.6  -2.6 ± 2.0  0.979*
Baseline PSD (dB) 2.8 (2.0 to 3.6) 2.2 (1.9 to 3.8)  0.676†
Baseline VFI (%) 97.0 (94.0 to 98.0)  95.0 (91.0 to 98.0) 0.454†
IOP (mmHg)
Pretreatment IOP 16.0 (13.5 to 18.0) 15.0 (13.0 to 18.0) 0.960†
Mean IOP 13.1 ± 1.8 13.4 ± 1.8 0.514*
IOP fluctuation 1.5 (1.4 to 1.8) 1.6 (1.4 to 1.8) 0.584†
Peak IOP 16.0 ± 2.3  16.2 ± 2.3  0.731*
IOP at progression 13.3 ± 2.6 13.3 ± 2.3 0.928*
Difference from mean IOP at progression (%) 1.9 ± 13.1 -0.4 ± 10.9 0.544*
MOPP 49.1 ± 6.9 51.6 ± 5.1  0.275*
SPP 106.0 ± 14.1 112.1 ± 10.7 0.129*
DPP 58.2 ± 8.7 59.9 ± 7.6 0.510*
Disc hemorrhage 8 (38.1)    7 (35.0) 0.999‡
OCT
Baseline RNFLT (μm) 85.4 ± 8.0 76.5 ± 8.4  0.001*
Baseline GCIPLT (μm) 74.7 ± 5.2 71.3 ± 8.6  0.135*
Location of RNFL defect 0.018‡
Superior 7 (33.3) 1 (5.0)
Inferior 13 (61.9) 13 (65.0)
Both 1 (4.8) 6 (30.0)
Location of GCIPL defect 0.310‡
None 3 (14.3) 2 (10.0)
Superior 2 (9.5) 0 (0.0)
Inferior 11 (52.4) 10 (50.0)
Both 4 (19.0) 8 (40.0)
GCIPL ROC (μm/yr) -0.7 (-1.1 to -0.4) -1.0 (-1.6 to -0.8) 0.011†
RNFL ROC (μm/yr) -1.3 (-1.9 to -0.8) -0.7 (-1.1 to -0.4) 0.010†
Values are presented as mean ± standard deviation, median (range), or number (%); p < 0.05 was considered to be statistically significant.
RNFL = retinal nerve fiber layer; GCIPL = ganglion cell–inner plexiform; CCT = central corneal thickness; MD = mean deviation; PSD 
= pattern standard deviation; VFI = visual field index; IOP = intraocular pressure; MOPP = mean ocular perfusion pressure; SPP = sys-
tolic perfusion pressure; DPP = diastolic perfusion pressure; OCT = optical coherence tomography; RNFLT = retinal nerve fiber layer 
thickness; GCIPLT = ganglion cell-inner plexiform layer thickness; ROC = rate of change. 
*Student’s t-test; †Mann-Whitney U-test; ‡Chi-squared test.
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patients included in the study, 15 patients showed signifi-
cant progression at the peripapillary RNFL (Fig. 1A-1D) 
and 14 patients at the macular GCIPL (Fig. 2A-2D). Twelve 
patients demonstrated progression in both regions, but ear-
lier structural progression was identified at the RNFL in 
six of these patients and at the GCIPL in the other six pa-
tients. For comparisons, the 20 patients who showed pro-
gression at the macular GCIPL first were categorized into 
the “GCIPL progression first” group and those 21 patients 
who showed their first progression at the peripapillary 
RNFL were categorized into the “RNFL progression first” 
group. 
Statistical analyses
All continuous data are presented as mean ± standard 
deviation for normative data, and as median (range) for 
non-normative data. All categorical data were presented as 
a number and percentage of the group. The distribution of 
data for each parameter was determined using Shapiro’s 
test. Comparisons of normally distributed continuous data 
were performed using the independent Student’s t-test and 
those data that did not follow the normal distribution were 
compared using the Mann-Whitney U-test. Comparisons 
of categorical data were performed using the chi-squared 
test. Simple and multiple regression analyses were per-
formed to identify clinical parameters associated with the 
region of structural progression. Those parameters that 
showed statistically significant p-values at the level of sim-
ple regression were carried forward to the multiple regres-
sion step. All statistical analyses were performed using the 
R statistical software ver. 3.6 (R Foundation for Statistical 
Computing, Vienna, Austria). A p-value less than 0.05 was 
considered statistically significant. 
Results
Patient demographics
A total of 41 patients were enrolled in the present study. 
The RNFL progression first group consisted of 21 patients. 
Thirteen patients (61.9 %) were males and 46.3 ± 17.3 years 
old on average. The GCIPL progression first group consist-
ed of 20 patients; 11 (55.5 %) were males, and were 60.9 ± 
16.2 years old on average. The results of the comparisons 
of demographics between the two groups are illustrated in 
detail in Table 1. While the percentage of males did not 
differ between the two groups, the GCIPL progression first 
group was significantly older (p = 0.008). The two groups 
also did not show significant differences in the percentages 
of patients diagnosed with hypertension or diabetes melli-
tus. No parameters regarding blood pressure showed a sta-
tistically significant difference. Progression was detected 
earlier in the GCIPL progression first group (40.5 ± 11.0 
months) than in the RNFL progression first group (54.2 ± 
14.8 months, p = 0.002). 
Comparison of ocular characteristics
Table 2 presents the comparisons of ocular characteris-
tics between the RNFL progression first group and GCIPL 
progression first group. The axial length between the two 
groups was similar. The central corneal thickness was 
slightly thicker on average in the RNFL progression first 
group (p = 0.045). At baseline, the RNFL progression first 
group showed greater RNFL thickness (85.4 ± 8.0 vs. 76.5 
± 8.4 mm/yr, p = 0.001), but similar mean deviation (p = 
0.979) and pattern standard deviation (p = 0.832) in com-
parison to the GCIPL progression first group. During the 
follow-up period, no parameters regarding IOP showed 
statistically signif icant differences between the two 
groups. The GCIPL progression first group showed faster 
rates of GCIPL loss (p = 0.033) whereas the RNFL pro-
gression first group did not show faster loss rates in RNFL 
thickness (p = 0.084). At baseline, the two groups showed 
statistically significant differences in the location of initial 
RNFL defects (p = 0.018) while no difference was ob-
served in the location of initial GCIPL defects (p = 0.310). 
Predictors of the region of structural progression
The clinical parameters were subjected to logistic re-
gression analyses to find associations with the region of 
structural progression of the disease (Table 3). The simple 
logistic regression analyses indicated age (odds ratio [OR], 
1.053; 95% confidence interval [CI], 1.010–1.098; p = 0.015), 
baseline RNFL thickness (OR, 0.876; 95% CI, 0.799–0.962; 
p = 0.005), and time until progression (OR, 0.918; 95% CI, 
0.862–0.977; p = 0.007) to be statistically significant. The 
statistically significant parameters at the level of simple re-
gression were then carried forward to multiple logistic re-
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Table 3. Simple and multiple logistic regression analyses to find predictors of the region of structural progression
　
Univariate Multivariate
OR (95% CI) p-value OR (95% CI) p-value
Age 1.053 (1.010–1.098) 0.015 1.051 (1.001–1.105) 0.046
Sex, male 0.752 (0.216–2.614) 0.654 - -
Blood pressure
Mean SBP 1.047 (0.991–1.105) 0.102 - -
Maximum SBP 1.032 (0.984–1.082) 0.197 - -
Minimum SBP 1.054 (0.996–1.115) 0.067 - -
SBP fluctuation 0.962 (0.827–1.119) 0.618 - -
Mean DBP 1.035 (0.955–1.121) 0.401 - -
Maximum DBP 1.008 (0.947–1.073) 0.795 - -
Minimum DBP 1.023 (0.949–1.102) 0.557 - -
DBP fluctuation 0.941 (0.754–1.173) 0.588 - -
MAP 1.049 (0.974–1.129) 0.205 - -
Axial length 0.658 (0.345–1.257) 0.205 - -
CCT 0.980 (0.961–1.001) 0.059 - -
IOP
Baseline IOP 0.976 (0.762–1.248) 0.844 - -
Mean IOP 1.129 (0.791–1.613) 0.503 - -
IOP fluctuation 1.413 (0.358–5.579) 0.622 - -
Peak IOP 1.051 (0.800–1.380) 0.723 - -
MOPP 1.061 (0.955–1.178) 0.270 - -
SPP 1.041 (0.988–1.097) 0.132 - -
DPP 1.027 (0.951–1.109) 0.500 - -
Baseline RNFLT 0.876 (0.799–0.962) 0.005 0.917 (0.830–1.013) 0.089
Baseline GCIPLT 0.929 (0.844–1.023) 0.135
RNFL defect at baseline
Superior 0.143 (0.015–1.331) 0.087 - -
Inferior 1.143 (0.320–4.081) 0.837 - -
Both 8.571 (0.927–79.272) 0.058 - -
GCIPL defect at baseline 
None 0.630 (0.093–4.244) 0.866 - -
Superior 1.111 (0.588–2.100) 0.746 - -
Inferior 0.818 (0.236–2.835) 0.752 - -
Both 2.667 (0.648–10.972) 0.174 - -
Visual field
Baseline MD 0.995 (0.707–1.402) 0.978 - -
Baseline PSD 1.040 (0.729–1.484) 0.827 - -
Disc hemorrhage 0.875 (0.245–3.124) 0.837 - -
Systemic medical conditions
Hypertension 3.200 (0.844–12.135) 0.087 - -
DM 0.224 (0.023–2.202) 0.199 - -
Time until progression 0.918 (0.862–0.977) 0.007 0.912 (0.840–0.991) 0.047
p < 0.05 was considered to be statistically significant. 
OR = odds ratio; CI = confidence interval; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; 
CCT = central corneal thickness; IOP = intraocular pressure; MOPP = mean ocular perfusion pressure; SPP = systolic perfusion pressure; 
DPP = diastolic perfusion pressure; RNFLT = retinal nerve fiber layer thickness; GCIPLT = ganglion cell-inner plexiform thickness; 
GCIPL = ganglion cell-inner plexiform; MD = mean deviation; PSD = pattern standard deviation; DM = diabetes mellitus. 
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gression. According to the results, macular GCIPL pro-
gression was more likely to occur first in older patients 
(OR, 1.051; 95% CI, 1.001–1.105; p = 0.046). Patients who 
took longer until they showed their first structural progres-
sion were more likely to show progression in the peripapil-
lary RNFL rather than the macular GCIPL (OR, 0.912; 
95% CI, 0.840–0.991; p = 0.029).
Discussion
The present study investigated the clinical characteris-
tics of early NTG patients who either showed their first 
structural progression at GCIPL or RNFL and attempted 
to identify clinical parameters associated with the region 
of structural progression. The results of our study have re-
vealed that those patients who showed structural progres-
sion first at the peripapillary RNFL were younger and had 
thicker RNFL at baseline. According to regression analy-
ses, the first structural progression was more likely to oc-
cur at the GCIPL for older patients. Patients who took lon-
ger to show the first structural progression were more 
likely to show progression first at the peripapillary RNFL.
The diagnostic accuracy of the macular GCIPL has been 
actively investigated [10,15,16]. Not only the lack of a floor 
effect but also the lower inter-subject anatomic variability 
of the macula, especially in comparison to the optic nerve 
head, has made it an attractive topic [8,17]. Notable studies 
on this topic include that by Hou et al. [18], who examined 
open-angle glaucoma (OAG) patients that demonstrated 
progressive thinning at either RNFL or GCIPL. They con-
cluded that both the GCIPL and RNFL were mutually pre-
dictive of VF deterioration. Bussel et al. [19], on the other 
hand, argued that RNFL analysis remained the most accu-
rate tool of diagnosis for structural progression in glauco-
ma. A systemic review of relevant literature by Oddone et 
al. [8] found that RNFL analysis is preferable to GCIPL 
analysis. The superiority between RNFL and GCIPL was 
debated during the World Glaucoma Association Consen-
sus Meeting on Progression of Glaucoma, but no consen-
sus was reached [20]. What seems to be at least agreed 
upon based on the recent literature is that the GCIPL 
serves as a useful adjunct in glaucoma management.
Why some patients first show their first structural pro-
gression at the GCIPL or RNFL is still unknown. In theo-
ry, the glaucomatous damage that begins at the level of the 
lamina cribrosa may cause retrograde degeneration of 
RGC axons. In this context, the signs of structural damage 
should first be observed near the disc and subsequently ap-
pear at the macular GCIPL as the soma and dendrites of 
RGCs begin to degenerate [21,22]. However, others posi-
tioned against this argument have contended that optic 
nerve damage first affects the dendrites and soma, leading 
to a thinning of the GCIPL in the macula [21]. The subse-
quent loss of axons then provokes thinning of the nerve fi-
ber layer. However, the mechanism behind the structural 
progression remains elusive and clinical factors that pre-
dispose glaucoma patients to progression in one region 
over the other continue to be perplexing.  
Recent studies have attempted to explain regions of first 
structural change with different patterns in which the 
damage progresses in glaucoma. Notably, Kim et al. [10] 
have postulated that there exist two predominant patterns 
of glaucoma damage: (1) an infero-inferior peripapillary 
RNFL defect that is preceded by RGC changes outside the 
macula, and (2) GCIPL changes within the macula that oc-
cur before corresponding peripapillary RNFL changes 
[23]. According to their studies, the former may first be 
detected on OCT scans as a change in RNFL and not the 
GCIPL because the ganglion cell changes preceding the 
infero-inferior RNFL damage tend to take place in an area 
beyond the 36 mm2 of the macula covered by the GCIPL 
scan [24]. The findings of our study appear to support the 
conclusions of these aforementioned reports. Our investi-
gation demonstrated that patients who exhibited structural 
progression later during the course of their follow-up were 
more likely to show progression at the peripapillary RNFL 
rather than at the macular GCIPL. By applying Kim’s hy-
pothesis to our results, we can extrapolate that patients 
who demonstrated structural changes at the peripapillary 
RNFL first possibly did so because their damage in the 
GCIPL layer near the macula went undetected by OCT. 
Further, our study supports arguments of previous investi-
gations contending that glaucomatous damage occurs in 
multiple different patterns not only between different indi-
viduals but also within the same individual at the same 
time. However, the results of this study must also be inter-
preted in the context of baseline differences in the RNFL 
thickness and age at diagnosis between the two groups. 
Although the difference was not significant in the regres-
sion analyses, the RNFL progression first group showed 
thicker RNFL at baseline. Previous studies have reported a 
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negative association between the baseline RNFL thickness 
and the rate of reduction of RNFL thickness [2]. It is possi-
ble that the structural progression was first detected at the 
RNFL first in the RNFL progression first group simply 
because the baseline RNFL thickness was not as close to 
the floor of the RNFL measurement as their counterpart. 
In this regard, additional studies are needed to validate our 
results. 
The results of our study also suggest that the region of 
the first structural region is more likely to be the macular 
GCIPL in older patients (OR, 1.051; 95% CI, 1.001–1.105; p 
= 0.046). Our results should be interpreted in comparison 
to age-related thinning of the GCIPL. Previous studies 
have reported that both RNFL and GCIPL thicknesses 
naturally decrease with time, approximately at -3.001 and 
-0.14 to -0.318 μm/yr, respectively [24,25]. This thinning, 
according to studies, is independent of glaucomatous pro-
gression. Based on these results, the investigators have 
added that the decrease in thickness does not always indi-
cate disease progression and that age-related change should 
be accounted for in examining measurements [24]. Sup-
porting this hypothesis, our comparisons revealed that the 
baseline RNFL thickness was greater for the GCIPL pro-
gression first group, whose constituents were older on av-
erage. When age was adjusted by logistic regression analy-
sis, however, the difference in baseline RNFLT between 
the two groups was statistically insignificant. With regard 
to the age-related loss of macular thickness, multiple 
mechanisms have been suggested. One of the most prom-
ising theories suggests the deterioration of the retinal mi-
crocirculation [26]. Previous reports have found a decrease 
in the density of retinal microvessels and associated micro-
circulation to coexist with thinning of the macular layers 
[27]. Hence, the regressed perfusion of the retina was as-
sumed to be the reason behind decreased visual function 
with aging [28]. However, it must be noted that numerous 
studies have attributed the progression of glaucoma to vas-
cular dysfunction in the past as well [29-31]. Significantly 
decreased vessel density in the GCIPL has been identified 
in glaucoma. In fact, the microvascular changes were able 
to distinguish glaucoma from healthy eyes [32-34]. In one 
study, the level of macular vessel density even explained 
the different severities of glaucomatous damage [35]. Dis-
turbed retinal hemodynamics appears to play a critical role 
in the pathogenesis of OAG [36]. In this regard, the associ-
ation between age and progression at the macular GCIPL 
per our analyses may hint at the possible pathogenic mech-
anism of glaucomatous damage at the macula. Further-
more, we believe that our study compels further examina-
tions to ascertain whether the age-related decline in retinal 
perfusion aggravates structural progression in glaucoma. 
There were several limitations to the present study that 
should be noted. First, this study had a retrospective de-
sign. While associations between age and GCIPL thinning 
and between progression time and RNFL thinning were 
found through the retrospective collection of data, the 
causal relationships between the parameters cannot be as-
certained due to the nature of the study design. Second, 
the study results may not be generalized. The study popu-
lation consisted of those referred to a tertiary center for 
specialized management and were only of the Korean pop-
ulation, among whom NTG is known to be more prevalent 
than OAG with high IOP. Third, the small number of study 
participants may have affected the results. Despite the lim-
itations, however, we believe that clear relationships be-
tween age and GCIPL progression and between time until 
first structural progression and RNFL progression were 
firmly established in our study. 
In conclusion, the region of structural progression in 
glaucoma may be predicted by the clinical characteristics 
of patients. Patients who are younger and have thicker 
RNFL at baseline tended to show structural progression 
first at the peripapillary RNFL. In patients who tended to 
show structural progression later during the course of fol-
low-up, the region of first structural progression was more 
likely to be the peripapillary RNFL. Further studies are 
needed to determine the mechanism that explains the re-
gion of first structural progression.
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